DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer

2021 ◽  
Vol 235 ◽  
pp. 105033
Author(s):  
Sai Kiran S.S. Pindiprolu ◽  
Praveen T. Krishnamurthy ◽  
Chetan Dev ◽  
Pavan Kumar Chintamaneni
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Gamma Secretase ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor

scholarly journals Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer

Oncotarget ◽  
2016 ◽  
Vol 8 (2) ◽  
pp. 2320-2328 ◽  
Author(s):  
Marzia A. Locatelli ◽  
Philippe Aftimos ◽  
E. Claire Dees ◽  
Patricia M. LoRusso ◽  
Mark D. Pegram ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Gamma Secretase ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor

Abstract 3439: Sulindac sulfide as a gamma secretase modifier to target triple negative breast cancer

2019 ◽  
Author(s):  
Fokhrul Hossain ◽  
Deniz A Ucar ◽  
Samarpan Majumder ◽  
Margarite Matossian ◽  
Keli Xu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Gamma Secretase ◽  
Sulindac Sulfide
Sign in / Sign up

Export Citation Format

Share Document